We are live on ! Find out more
DY

Dowling & Yahnke Portfolio holdings

AUM $2.15B
1-Year Est. Return 10.82%
This Fund
S&P 500
This Quarter Est. Return
-4.54%
1 Year Est. Return
-10.82%
3 Year Est. Return
+34.82%
5 Year Est. Return
+71.23%
10 Year Est. Return
–
AUM
$2.15B
AUM Growth
+$21.9M
Cap. Flow
+$140M
Cap. Flow %
6.52%
Top 10 Hldgs %
29.72%
Holding
387
New
13
Increased
178
Reduced
139
Closed
14

Top Buys

Rank Stock Value
1
DFAI
Dimensional International Core Equity Market ETF
DFAI
+$30.3M
2
BSV icon
Vanguard Short-Term Bond ETF
BSV
+$24.2M
3
VXUS icon
Vanguard Total International Stock ETF
VXUS
+$23.3M
4
VCSH icon
Vanguard Short-Term Corporate Bond ETF
VCSH
+$13.8M
5
VTIP icon
Vanguard Short-Term Inflation-Protected Securities Index Fund
VTIP
+$10.3M

Top Sells

Rank Stock Value
1
VTEB icon
Vanguard Tax-Exempt Bond Index Fund
VTEB
+$16.8M
2
VEU icon
Vanguard FTSE All-World ex-US ETF
VEU
+$4.06M
3
NOC icon
Northrop Grumman
NOC
+$2.81M
4
LDOS icon
Leidos
LDOS
+$2.15M
5
SAIC icon
Saic
SAIC
+$1.57M

Sector Composition

Rank Sector Weight
1 Miscellaneous 51.91%
2 Technology 10.65%
3 Healthcare 9.36%
4 Financials 6.57%
5 Consumer Staples 5.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BNL icon
351
Broadstone Net Lease
BNL
$4.32B
$205K 0.01%
13,216
– –
DELL icon
352
Dell
DELL
$295B
$202K 0.01%
5,900
-130
-2% -$5.47K
KMI icon
353
Kinder Morgan
KMI
$70.3B
$195K 0.01%
11,708
-113
-1% -$2.01K
GOSS icon
354
Gossamer Bio
GOSS
$83.2M
$181K 0.01%
15,100
– –
RNAM
355
DELISTED
Avidity Biosciences
RNAM
$175K 0.01%
10,691
-590
-5% -$11.3K
LUMN icon
356
Lumen
LUMN
$6.23B
$172K 0.01%
23,678
-2,672
-10% -$27.2K
GOF icon
357
Guggenheim Strategic Opportunities Fund
GOF
$2.15B
$164K 0.01%
10,705
+340
+3% +$5.66K
BMEZ icon
358
BlackRock Health Sciences Trust II
BMEZ
$1.05B
$149K 0.01%
+10,000
New +$165K
IEZ icon
359
iShares US Oil Equipment & Services ETF
IEZ
$386M
$144K 0.01%
10,000
– –
ONCT
360
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$134K 0.01%
7,523
– –
CMRX
361
DELISTED
Chimerix, Inc.
CMRX
$124K 0.01%
64,055
– –
OUST icon
362
Ouster
OUST
$2.5B
$106K ﹤0.01%
+10,955
New +$169K
VTRS icon
363
Viatris
VTRS
$18.8B
$102K ﹤0.01%
12,023
-865
-7% -$8.51K
GERN icon
364
Geron
GERN
$970M
$91K ﹤0.01%
39,047
– –
TCON
365
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$79K ﹤0.01%
2,373
– –
SNCE
366
DELISTED
Science 37 Holdings, Inc. Common Stock
SNCE
$68K ﹤0.01%
2,113
-1,000
-32% -$37.1K
GRFS
367
Grifois
GRFS
$5.23B
$67K ﹤0.01%
10,955
– –
SIRI icon
368
SiriusXM
SIRI
$9.62B
$60K ﹤0.01%
1,053
+23
+2% +$1.45K
SRTA
369
Strata Critical Medical Inc
SRTA
$528M
$40K ﹤0.01%
10,000
– –
SLQT icon
370
SelectQuote
SLQT
$91.8M
$40K ﹤0.01%
55,000
– –
LCTX icon
371
Lineage Cell Therapeutics
LCTX
$281M
$36K ﹤0.01%
32,263
– –
FBIO icon
372
Fortress Biotech
FBIO
$92.4M
$17K ﹤0.01%
1,333
– –
STAB
373
DELISTED
Statera Biopharma, Inc. Common Stock
STAB
$4K ﹤0.01%
28,875
– –
AWK icon
374
American Water Works
AWK
$27.5B
– –
-1,655
Closed -$246K
CHD icon
375
Church & Dwight Co
CHD
$24B
– –
-2,499
Closed -$232K
12 13 14
15
16

Similar funds

AC
Alleghany Corporation New York $2.21B AUM 10.5% 1-Year Est. Return
CCM
Covington Capital Management Los Angeles, California $2.32B AUM 12.18% 1-Year Est. Return
MIAN
Mariner Independent Advisor Network Overland Park, Kansas $2.33B AUM 14.85% 1-Year Est. Return
APA
American Portfolios Advisors Holbrook, New York $2.36B AUM 14.59% 1-Year Est. Return
IC
Inverness Counsel New York $1.8B AUM 9.9% 1-Year Est. Return
SCA
Salient Capital Advisors Houston, Texas $1.74B AUM 12.95% 1-Year Est. Return
ACM
AlphaCrest Capital Management New York $1.64B AUM 23.4% 1-Year Est. Return
W
Wealthsimple Toronto, Ontario, Canada $2.69B AUM 18.39% 1-Year Est. Return

Dowling & Yahnke's Q3 2022 Portfolio in Review

As of Q3 2022, Dowling & Yahnke held 387 positions worth $2.15B, up 1% from $2.13B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Dowling & Yahnke deployed $140M of net new capital in Q3 2022, opening 13 new positions and adding to 178 existing holdings. Its largest new stake was Dimensional US High Profitability ETF: 161,010 shares worth $3.44M.

By sector, the portfolio is most concentrated in Miscellaneous at 52% of assets, up from 49% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Vanguard Tax-Exempt Bond Index Fund, an estimated $16.8M trimmed.

  • Dowling & Yahnke's largest Q3 2022 buy was Dimensional US High Profitability ETF: 161,010 shares worth $3.44M.
  • Dowling & Yahnke added most to Dimensional International Core Equity Market ETF in Q3 2022, an estimated $30.3M increase.
  • Dowling & Yahnke's biggest Q3 2022 reduction was Vanguard Tax-Exempt Bond Index Fund, cutting an estimated $16.8M.
  • Dowling & Yahnke fully exited Saic in Q3 2022, selling an estimated $1.57M.
  • Dowling & Yahnke's ten largest holdings make up 30% of its $2.15B portfolio in Q3 2022.
  • Dowling & Yahnke opened 13 new positions and closed 14 in Q3 2022.
  • Dowling & Yahnke's portfolio value rose 1% quarter-over-quarter to $2.15B.

Based on Dowling & Yahnke's 13F filing for Q3 2022, filed 3 Nov 2022.